We are live on ! Find out more
DnB Asset Management

DnB Asset Management Portfolio holdings

AUM $28B
1-Year Est. Return 26%
This Fund
S&P 500
This Quarter Est. Return
+3.33%
1 Year Est. Return
+26%
3 Year Est. Return
+97.1%
5 Year Est. Return
+115.87%
10 Year Est. Return
+443.63%
AUM
$28.7B
AUM Growth
+$1.92B
Cap. Flow
+$1.12B
Cap. Flow %
3.92%
Top 10 Hldgs %
44.24%
Holding
782
New
51
Increased
433
Reduced
192
Closed
51

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$467M
2
V icon
Visa
V
+$259M
3
MA icon
Mastercard
MA
+$206M
4
HPQ icon
HP
HPQ
+$191M
5
TEAM icon
Atlassian
TEAM
+$186M

Sector Composition

Rank Sector Weight
1 Technology 39.4%
2 Communication Services 14.24%
3 Financials 14%
4 Consumer Discretionary 10.61%
5 Healthcare 7.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARQT icon
651
Arcutis Biotherapeutics
ARQT
$3.26B
$807K ﹤0.01%
27,786
+802
+3% +$20.5K
NIO icon
652
NIO
NIO
$12.1B
$799K ﹤0.01%
156,760
-67,903
-30% -$419K
HAS icon
653
Hasbro
HAS
$13.3B
$798K ﹤0.01%
+9,735
New +$763K
NVTS icon
654
Navitas Semiconductor
NVTS
$3.44B
$774K ﹤0.01%
+108,401
New +$1.04M
KRYS icon
655
Krystal Biotech
KRYS
$9.81B
$763K ﹤0.01%
3,093
+737
+31% +$155K
PCVX icon
656
Vaxcyte
PCVX
$8.67B
$760K ﹤0.01%
16,471
+5,235
+47% +$234K
CRNX icon
657
Crinetics Pharmaceuticals
CRNX
$8.93B
$749K ﹤0.01%
16,089
+6,934
+76% +$309K
XP icon
658
XP
XP
$8.37B
$721K ﹤0.01%
44,043
-114,994
-72% -$2.02M
NAMS icon
659
NewAmsterdam Pharma
NAMS
$3.34B
$706K ﹤0.01%
+20,119
New +$732K
CYTK icon
660
Cytokinetics
CYTK
$10.5B
$704K ﹤0.01%
11,079
+869
+9% +$54.1K
MSGS icon
661
Madison Square Garden
MSGS
$9.43B
$690K ﹤0.01%
+2,669
New +$608K
TIC
662
TIC Solutions Inc
TIC
$2.25B
$680K ﹤0.01%
67,257
+32,543
+94% +$362K
QURE icon
663
uniQure
QURE
$3.2B
$654K ﹤0.01%
27,342
+15,540
+132% +$600K
SLNO
664
DELISTED
Soleno Therapeutics
SLNO
$651K ﹤0.01%
14,071
+7,710
+121% +$423K
VUZI icon
665
Vuzix
VUZI
$217M
$649K ﹤0.01%
171,698
+102,637
+149% +$323K
VRDN icon
666
Viridian Therapeutics
VRDN
$2.61B
$635K ﹤0.01%
+20,420
New +$560K
BZ icon
667
Kanzhun
BZ
$7.8B
$632K ﹤0.01%
31,012
ZENA
668
ZenaTech Inc
ZENA
$152M
$631K ﹤0.01%
197,138
+51,668
+36% +$215K
TKO icon
669
TKO Group
TKO
$13.8B
$631K ﹤0.01%
+3,017
New +$586K
HTZ icon
670
Hertz
HTZ
$756M
$626K ﹤0.01%
+121,864
New +$665K
SNDX icon
671
Syndax Pharmaceuticals
SNDX
$1.82B
$625K ﹤0.01%
29,760
+6,466
+28% +$113K
ZWS icon
672
Zurn Elkay Water Solutions
ZWS
$8.47B
$596K ﹤0.01%
12,818
ANNX icon
673
Annexon
ANNX
$883M
$594K ﹤0.01%
118,324
+33,801
+40% +$129K
OCUL icon
674
Ocular Therapeutix
OCUL
$2.03B
$540K ﹤0.01%
+44,451
New +$540K
TGTX icon
675
TG Therapeutics
TGTX
$7.52B
$532K ﹤0.01%
17,845
+3,940
+28% +$129K

Similar funds

DnB Asset Management's Q4 2025 Portfolio in Review

As of Q4 2025, DnB Asset Management held 782 positions worth $28.7B, up 7.2% from $26.7B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

DnB Asset Management deployed $1.12B of net new capital in Q4 2025, opening 51 new positions and adding to 433 existing holdings. Its largest new stake was Petrobras: 1,837,813 shares worth $21.8M.

By sector, the portfolio is most concentrated in Technology at 39% of assets, down from 42% a quarter earlier, followed by Communication Services and Financials.

On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $356M trimmed.

  • DnB Asset Management's largest Q4 2025 buy was Petrobras: 1,837,813 shares worth $21.8M.
  • DnB Asset Management added most to Meta Platforms (Facebook) in Q4 2025, an estimated $467M increase.
  • DnB Asset Management's biggest Q4 2025 reduction was Alphabet (Google) Class A, cutting an estimated $356M.
  • DnB Asset Management fully exited MasTec in Q4 2025, selling an estimated $59.7M.
  • DnB Asset Management's ten largest holdings make up 44% of its $28.7B portfolio in Q4 2025.
  • DnB Asset Management opened 51 new positions and closed 51 in Q4 2025.
  • DnB Asset Management's portfolio value rose 7.2% quarter-over-quarter to $28.7B.

Based on DnB Asset Management's 13F filing for Q4 2025, filed 5 Feb 2026.